Effects of deuterium modification on the electropharmacological profile of anti-atrial fibrillatory drug
Project/Area Number |
20K16136
|
Research Category |
Grant-in-Aid for Early-Career Scientists
|
Allocation Type | Multi-year Fund |
Review Section |
Basic Section 48030:Pharmacology-related
|
Research Institution | Toho University |
Principal Investigator |
|
Project Period (FY) |
2020-04-01 – 2023-03-31
|
Project Status |
Completed (Fiscal Year 2022)
|
Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2022: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2021: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2020: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
Keywords | 重水素化 / 抗不整脈薬 / 心房細動 / 病態モデル / QT延長 / 心室不整脈 / 心房有効不応期 / 心室再分極 / 心血管 |
Outline of Research at the Start |
抗不整脈薬dronedaroneは、心房細動に対し高い有効性を示す一方で、心不全および致死性心室不整脈といった有害作用のリスクを増加させることからその安全性には課題が残る。本研究では、dronedaroneの有害作用を減弱させるための手段として、薬物の薬理学的特性を変化させ得る重水素化に着目した。しかしながら、重水素化がdronedaroneの心血管系に対する多様な薬理作用に及ぼす影響を十分には解明できていない。そこで、臨床予測性が高く、薬物の循環薬理作用を多角的に評価可能であるin vivoモデルを用いて、重水素化がdronedaroneの循環薬理作用に与える影響を解明する。
|
Outline of Final Research Achievements |
To investigate how deuteration can modify electropharmacological effects of antiarrhythmic drug, we assessed the effects of deuterated analogue of dronedarone, poyendarone, using the canine atrial fibrillation models, which were compared with those of dronedarone. The deuteration might enhance the drug-induced prolongation of atrial effective refractory period at high frequency of depolarization observed during AF episode, which can potentiate the inhibitory action on the paroxysmal atrial fibrillation. Meanwhile, the deuteration would hardly affect the defibrillation effect on the persistent atrial fibrillation, whereas it can attenuate the risk for QT prolongation and ventricular arrhythmias. Poyendarone would have more potent anti-atrial fibrillatory action and favorable cardiovascular safety profile than dronedarone, and therefore is a promising anti-atrial fibrillatory drug candidate.
|
Academic Significance and Societal Importance of the Research Achievements |
心房細動の治療に使用される既存の抗不整脈薬は、心房組織への選択性または心房細動の病態に対する特異性が低く、心室組織に対しても電気生理学的作用を示し、致死性心室不整脈を誘発する可能性がある。本研究は、その有害作用を減弱する手段として重水素化に着目し、重水素化は抗不整脈薬の心房細動に対する有効性を増強し、心室不整脈の誘発リスクを減弱することを示した。それゆえ、重水素化が抗不整脈薬の循環薬理作用を修飾する上で有益な手段となる可能性を見出した。既存薬dronedaroneの重水素化誘導体poyendaroneは、より有効かつ安全な治療薬として心房細動患者の薬物治療に貢献できると考える。
|
Report
(4 results)
Research Products
(25 results)
-
-
-
-
-
-
[Journal Article] Imatinib induces diastolic dysfunction and ventricular early-repolarization delay in the halothane-anesthetized dogs: Class effects of tyrosine kinase inhibitors.2022
Author(s)
Chiba Koki, Kambayashi Ryuichi, Onozato Mayu, Goto Ai, Izumi-Nakaseko Hiroko, Takei Yoshinori, Matsumoto Akio, Tanaka Koichiro, Kanda Yasunari, Fukushima Takeshi, Sugiyama Atsushi
-
Journal Title
Journal of Pharmacological Sciences
Volume: 150
Issue: 3
Pages: 154-162
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
[Journal Article] An exploratory analysis of effects of poyendarone, a deuterated analogue of dronedarone, on the canine model of paroxysmal atrial fibrillation2021
Author(s)
Ryuichi Kambayashi, Ai Goto, Yoshio Nunoi, Mihoko Hagiwara-Nagasawa, Hiroko Izumi-Nakaseko, Gopalakrishnan Venkatesan, Yoshinori Takei, Akio Matsumoto, Eric Chun Yong Chan, Atsushi Sugiyama
-
Journal Title
Naunyn-Schmiedeberg's archives of pharmacology
Volume: -
Issue: 6
Pages: 1103-1112
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Translational studies on anti-atrial fibrillatory action of oseltamivir by its in vivo and in vitro electropharmacological analyses2021
Author(s)
Ryuichi Kambayashi, Hiroko Izumi-Nakaseko, Ai Goto, Kazuya Tsurudome, Hironori Ohshiro, Taku Izumi, Mihoko Hagiwara-Nagasawa, Koki Chiba, Ryota Nishiyama, Satomi Oyama, Yoshio Nunoi, Yoshinori Takei, Akio Matsumoto, Atsushi Sugiyama
-
Journal Title
Frontiers in Pharmacology
Volume: 12
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
[Journal Article] In vivo characterization of anti-atrial fibrillatory potential and pharmacological safety profile of INa,L plus IKr inhibitor ranolazine using the halothane-anesthetized dogs2021
Author(s)
Yoshio Nunoi, Ryuichi Kambayashi, Ai Goto, Mihoko Hagiwara-Nagasawa, Koki Chiba, Hiroko Izumi-Nakaseko, Shinichi Kawai, Yoshinori Takei, Akio Matsumoto, Yoshinori Watanabe, Atsushi Sugiyama
-
Journal Title
Heart and Vessels
Volume: -
Issue: 7
Pages: 1088-1097
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
-
-